COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,742 Articles (22,502 medRxiv, 8,240 bioRxiv)

Most recent first Previous |  Page 31: Articles 301-310  | Next

A structural roadmap for the formation of the coronavirus nsp3/nsp4 double membrane vesicle pore and its implications for polyprotein processing and replication/transcription
Perry, J., Itskanov, S., Bilello, J. P., Lansdon, E.
10.1101/2025.04.10.648184 — Posted: 2025-04-11
Spatial Clustering of Interface Residues Enhances Few-Shot Prediction of Viral Protein Binding
Basse, M., Wang, D., Shakhnovich, E.
10.1101/2025.04.10.647895 — Posted: 2025-04-11
Agreement between self-reported COVID-19 and dried blood spot serology
Sheppard, N., Carroll, M. T. C., Borg, B. M., Toh, Z. Q., Licciardi, P., Smith, C. L., Ikin, J. F., Abramson, M. J., Walker-Bone, K., Lane, T. J.
10.1101/2025.04.08.25325501 — Posted: 2025-04-10
Implementation of oral health evidence-based practices in early care education settings across the U.S. during different COVID-19 periods
Tchoua, P., Patel, S., Starr, A. S., Rairigh, R., Smith, F., Willis, E. A.
10.1101/2025.04.09.25325529 — Posted: 2025-04-10
The Impacts of COVID-19 on routine immunization for children in Rwanda.
Mbonigaba, E., Yu, F., Renosa, M. D. C., Cho, F. N., Chen, Q., Chen, W., Denkinger, C. M., McMahon, S. A., Chen, S.
10.1101/2025.04.09.25325536 — Posted: 2025-04-10
Impact of Covid-19 Control Strategies on Health and GDP Growth Outcomes in 193 Sovereign Jurisdictions
Boyd, M., Baker, M. G., Kvalsvig, A., Wilson, N.
10.1101/2025.04.08.25325452 — Posted: 2025-04-10
Phase 2/3 open-label study on NVX-CoV-2601 (XBB.1.5) vaccine in previously COVID-19 mRNA vaccinated and vaccine-naive participants: a 6-month follow-up
Alves, K., Kotloff, K. L., McClelland, R. S., Hammershaimb, E. A., Kouassi, A., Plested, J. S., Kalkeri, R., Zhu, M., Cloney-Clark, S., Cai, Z., Smith, K., Kaba, M., Nelson, J., Mallory, R. M., Noriega, F.
10.1101/2025.04.09.25325550 — Posted: 2025-04-10
The ORF6 accessory protein contributes to SARS-CoV-2 virulence and pathogenicity in the naturally susceptible feline model of infection
Nooruzzaman, M., Butt, S. L., Rani, R., Ye, C., Martinez-Sobrido, L., Fang, Y., Diel, D. G.
10.1101/2025.04.09.647941 — Posted: 2025-04-10
Reconstructing the force of infection and immune fraction of the population via a single snapshot survey: a case study of COVID-19 in Japan
Okada, Y., Nishiura, H.
10.1101/2025.04.08.25325449 — Posted: 2025-04-09
Bayesian automatic screening of pneumoniaand lung lesions localization from CT scans. Acombined method toward a more user-centredand explainable approach
Moure Prado, A., Guerrero-Lopez, A., Arias-Londono, J. D., Godino-Llorente, J. I.
10.1101/2025.04.08.647710 — Posted: 2025-04-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).